Crossmark

Comment on: “A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal‑Onset Epilepsy”

Crossref DOI link: https://doi.org/10.1007/s40263-025-01157-9

Published Online: 2025-01-30

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Zhongxing

Tian, Mengzhe

Duan, Lincheng https://orcid.org/0000-0003-1937-1605
License Information

Text and Data Mining valid from 2025-01-30

Version of Record valid from 2025-01-30
More Information

Article History

Accepted: 7 January 2025

First Online: 30 January 2025

Declarations

:

: No funding was received for this research.

: The authors declare no conflicts of interest that pertain to this work.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Z.L.: methodology, formal analysis, and writing—original draft; M.T.: methodology and writing—original draft; L.D.: conceptualization, methodology, supervision, and writing—review and editing.

Document is current

Any future updates will be listed below